Breaking News

Quintiles Appoints Real-World VP

By Kristin Brooks | March 27, 2014

Blackburn brings two decades of experience

Stella Blackburn, M.B. B.S., has been appointed vice president and global head of Risk Management for Quintiles Real-World & Late Phase Research group. Dr. Blackburn will be responsible for leading risk management efforts in North America, EU and Asia-Pacific, and will develop benefit risk management services, assist customers with interpretation of pharmacovigilance legislation, and ensure compliance with regulations and best practices for the company’s real-world and late phase research efforts.

Dr. Blackburn has more than two decades of experience in the fields of pharmacovigilance and pharmacoepidemiology. She joins the company from the European Medicines Agency (EMA), where she spent more than 16 years in various roles, most recently as the EMA Risk Management Development and Scientific Lead. In this role, Dr. Blackburn was responsible for designing and implementing risk management public policy and processes used throughout Europe. Prior to joining the EMA, Dr. Blackburn worked in hospital medicine and also spent more than 11 years in the pharmaceutical industry in a variety of leadership roles.  

“Stella’s experience developing innovative risk management solutions for our customers is a tremendous addition to our team,” said Cynthia Verst, M.S., Pharm.D., president, Real-World & Late Phase Research at Quintiles. “Throughout her career, Stella has forged cross-sector partnerships — driving the sort of collaboration we are cultivating here at Quintiles — to develop comprehensive risk management policies and processes designed to protect patients and advance clinical research worldwide. She brings a range of unique safety expertise and experience that we can leverage across our business to better assist our customers with solutions to meet regulatory and reimbursement requirements for their products, and subsequent risk benefit monitoring.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important